![2101951-20-4: 3-((3R,4R)-4-Methyl-3-(methyl(5-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](https://veeprho.com/wp-content/uploads/2022/10/3-3R-4R-4-methyl-3-methyl-5-oxo-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-3-oxopropanenitrile.png)
2101951-20-4: 3-((3R,4R)-4-Methyl-3-(methyl(5-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Additional information on CAS 2101951-20-4
Catalogue No.
VE0010103
CAS No.
2101951-20-4
Molecular Formula
C16H20N6O2
Molecular Weight
328.38 g/mol
Parent drug
Tofacitinib
IUPAC Name
3-((3R, 4R)-4-Methyl-3-(methyl(5-oxo-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Synonyms
N/A
References
–
Status
In-stock
